Evidence mapPaperPMID 36769689Full record

ArticleJournal of clinical medicine2023

Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension.

Ann-Kathrin C Schäfer, Dennis Pieper, Hassan Dihazi, Gry H Dihazi, Stephan Lüders, Michael J Koziolek, Manuel Wallbach

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ann-Kathrin C SchäferDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.ORCID 0000-0003-2676-9670
Dennis PieperDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Hassan DihaziDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.ORCID 0000-0003-3417-0385
Gry H DihaziInstitute for Clinical Chemistry, University Medical Center Göttingen, 37075 Göttingen, Germany.ORCID 0000-0002-3214-7969
Stephan LüdersDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Michael J KoziolekDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Manuel WallbachDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.ORCID 0000-0002-1162-4682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with resistant hypertension (HTN) demonstrate an increased risk of chronic kidney disease and progression to end-stage renal disease; however, the individual course of progression is hard to predict. Assessing the stress-induced, urinary glycoprotein Dickkopf-3 (uDKK3) may indicate ongoing renal damage and consecutive estimated glomerular filtration rate (eGFR) decline. The present study aimed to determine the association between uDKK3 levels and further eGFR changes in patients with resistant HTN. In total, 31 patients with resistant HTN were included. Blood pressure and renal function were measured at baseline and up to 24 months after (at months 12 and 24). uDKK3 levels were determined exclusively from the first available spot urine sample at baseline or up to a period of 6 months after, using a commercial ELISA kit. Distinctions between different patient groups were analyzed using the unpaired t-test or Mann-Whitney test. Correlation analysis was performed using Spearman's correlation. The median uDKK3 level was 303 (interquartile range (IQR) 150-865) pg/mg creatinine. Patients were divided into those with high and low eGFR loss (≥3 vs. <3 mL/min/1.73 m²/year). Patients with high eGFR loss showed a significantly higher median baseline uDKK3 level (646 (IQR 249-2555) (n = 13) vs. 180 (IQR 123-365) pg/mg creatinine (n = 18),

Indexed as

chronic kidney diseaseDickkopf-3resistant hypertension

Identifiers

PMID36769689
PMCPMC9918035

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.